🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy #PrideMonth! All year round, we celebrate our #LGBTQ+ colleagues and this June, we reaffirm our commitment to fostering an inclusive environment where all backgrounds are embraced. We were thrilled to gather some of our teams to celebrate Pride and enjoy the summer weather!

We are thrilled to announce that for the fifth consecutive year, #Servier has been recognized as a Best Place to Work by Boston Business Journal. This honor reflects the exceptional talent of our team and the purpose that drives our work every day. lnkd.in/ewShRM54

We’re here at #BIO2025! It’s energizing to be surrounded by so many innovators who share the same passion for shaping the future of biotech and improving patient outcomes. Join us to explore how we can move science forward together!

At Servier, our One Innovation Engine powers breakthroughs in oncology and neurology, two areas where patients need us most. Learn more about our research approach: lnkd.in/esSSHFz3

Today, we honor Juneteenth - a day of celebration, reflection, and continued commitment. At Servier, we recognize the significance of this day in the lives of Black Americans and reaffirm our commitment to fostering a culture of equity. For resources: lnkd.in/e8KQRXuc

We’re thrilled to be seeing lots of new faces (and one familiar logo) in the Seaport this month during the #BIO Annual Meeting! Even more exciting? #Servier is growing, and we’re looking for talented individuals to join us! Check out our open roles here: lnkd.in/e9CaYpxA

June is #AMLAwarenessMonth, a time dedicated to supporting those affected by Acute Myeloid Leukemia. No one should have to face a cancer diagnosis alone. By raising awareness and sharing resources, we can help address this unmet patient need. Learn more: lnkd.in/e9dPrtUP

Last week at #BIO2025, Servier took an active part in key conversations at the heart of the biotech industry. Our team members were featured in several panels and high-level forums, reflecting our commitment to advancing science where the need is greatest. servier.us/blog/serviers-…

Since 2018, we have built a robust portfolio of precision therapies targeting hard-to-treat and IDH-mutant cancers, advancing care in AML, MDS, glioma and CCA. Explore how we’re shaping the future of oncology: servier.us

This past week, the Servier team welcomed team members from across the globe at the Saclay R&D Institute to celebrate #science and hold the first internal R&D Awards, recognizing the work done by our #researchers from early-stage to late-stage projects. Congrats to the winners!

At #Servier, we’re committed to advancing research in #neurology to deliver meaningful progress for patients and families. Discover how we’re shaping the future of refractory epilepsies, rare movement disorders and neuromuscular conditions: lnkd.in/esSSHFz3

Servier’s #Legal team is expanding, with several open #AssociateCounsel and #ContractManager roles! If you’re looking to join a dynamic and growing organization, this is a great opportunity. Apply here: lnkd.in/gRWqxyj9

As a company committed to innovative science to advance patient care, we’re supporting bold innovators in science. We were proud to recognize Cenos Therapeutics’ pioneering work in RNA therapeutics to meet critical unmet patient needs. Read more here: servier.us/blog/servier-h…

At #Servier, we’re pushing the boundaries of what’s possible for patients living with hard-to-treat and IDH-mutant cancers, through innovative, targeted therapies. Learn how we're driving progress in AML, MDS, CCA and more: servier.us

Servier’s #Legal function is building a team of contract managers that will be vital in launching a new contracting system. If you’re looking to join a dynamic and growing organization, this could be the perfect time to join the Servier team. Apply here: lnkd.in/gRWqxyj9

Today is #WorldBrainDay, a time dedicated to raising awareness of neurological disorders and promoting brain health. At Servier, we are deeply committed to advancing neuroscience through innovative research. Learn more about our efforts here: lnkd.in/e_i7mBjD

Servier team members and their families gathered to enjoy some warm weather fun during our annual summer outing! Learn more about Servier’s people-first culture: lnkd.in/gRWqxyj9

Positive long-term data from our Phase 3 AML trial were published in Blood Advances, demonstrating our steadfast commitment to improving outcomes for patients with IDH-mutated cancers. Read the full announcement here: lnkd.in/emeiqQvK

At Servier Pharmaceuticals, we’re lucky to have four young professionals from France working in our Boston office. From R&D to legal, communications and public affairs, they’re making a real impact at Servier. Learn more about the V.I.E program here: servier.us/blog/behind-th…

Happy #NationalInternDay! Today, we’re celebrating the contributions of our summer interns who have brought fresh perspectives and enthusiasm to Servier. Hear directly from our interns about what it’s been like to work at #Servier this summer.